We cooperate across the hospital/university campus to deliver comprehensive research programmes that span the full range of cancer diagnosis, molecular investigations of cancer cells, and delivery of cancer treatments. The Cancer Research UK Clinical Trials Unit is a world leader in the development and assessment of new cancer therapies.
Our aims are to develop new tools for diagnosing and treating cancer. We are developing new screening tools, and evaluating different therapies. These aims are supported by our laboratory studies that identify biomarkers and molecular defects in cancer cells. We have made significant advances in many areas which include colorectal cancer, bladder cancer and leukaemia.